NCT06936241

Brief Summary

The study is aimed at studying the effects of Circuit Weight Training (CWT) on functional capacity and quality of life in breast cancer patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
52

participants targeted

Target at P25-P50 for not_applicable breast-cancer

Timeline
Completed

Started Sep 2024

Shorter than P25 for not_applicable breast-cancer

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 11, 2024

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 10, 2025

Completed
21 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2025

Completed
12 days until next milestone

First Submitted

Initial submission to the registry

April 12, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

April 20, 2025

Completed
Last Updated

July 30, 2025

Status Verified

July 1, 2025

Enrollment Period

6 months

First QC Date

April 12, 2025

Last Update Submit

July 28, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Assessment of quality of life

    The 12-Item Short Form Survey (SF-12) is the abridged practical form of the SF-36. It is a widely used screening device for measuring physical, mental, and social well-being to assess quality of life. it consists of 2 components: Physical Component Summary (PCS-12) and Mental Component Summary (MCS-12). Its score ranges between 0-100. Higher score indicates better health.

    8 weeks

  • Assessment of functional capacity

    The 2-minute step test (TMST) will be used to measure exercise capacity for all participants in the study before and after treatment. The test simply requires that participants march in place as fast as possible for 2 minutes while lifting the knees to a height midway between their patella and iliac crest when standing. Performance on the test is defined as the number of right-side steps of the criterion height completed in 2 minutes.

    8 weeks

Secondary Outcomes (4)

  • Postural stability test

    8 weeks

  • Limits of stability test

    8 weeks

  • Single leg stability test

    8 weeks

  • Assessment of muscle strength

    8 weeks

Study Arms (2)

Circuit weight training and traditional physical therapy program

EXPERIMENTAL

The participants will do Circuit Weight Training in addition to traditional physical therapy program for 8 weeks

Other: Circuit weight trainingOther: Traditional physical therapy program

Traditional physical therapy program

ACTIVE COMPARATOR

The participants will receive traditional physical therapy program only for 8 weeks

Other: Traditional physical therapy program

Interventions

The Circuit Training protocol will be performed as follows: wall push-up, bridge on floor, single leg bridge, bird dog, windshield wiper, march in place, ball squat, squat with an overhead press, reverse pendulum, jumping rope, and spinal twist, 30-35 minutes, 3 times a week for 8 weeks

Circuit weight training and traditional physical therapy program

The participants will receive traditional physical therapy program in the form of therapeutic exercises to keep daily living activity by restoring the strength of flexors and abductors of the shoulder joint using the shoulder wheel and ladder. It will be performed 3 times per week for eight weeks

Circuit weight training and traditional physical therapy programTraditional physical therapy program

Eligibility Criteria

Age35 Years - 45 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Female with age between 35-45.
  • Body Mass Index (BMI) \< 25.
  • Patients diagnosed with non-metastatic (Stage 0-III) breast cancer.
  • All patients who are treated by neoadjuvant chemotherapy before surgery.

You may not qualify if:

  • Patients diagnosed with cancer metastasis.
  • Patients diagnosed with diseases of the nervous system (Parkinson's disease, peripheral nerve palsy) skeletal system (inflammatory diseases, scoliosis \>10 Cobb angle), or rheumatic diseases.
  • Patients with any current visual impairment that affected their daily living, vestibular disorder, neurological disorder, cognitive disorder, and any further medical condition that would prohibit them from participating safely.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Alhasnaa Sayed Farouk

Giza, Egypt

Location

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Maher H Ibrahim, Professor

    Cairo University

    STUDY DIRECTOR
  • Heba A. Abdulghafar, Professor

    Cairo University

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

April 12, 2025

First Posted

April 20, 2025

Study Start

September 11, 2024

Primary Completion

March 10, 2025

Study Completion

March 31, 2025

Last Updated

July 30, 2025

Record last verified: 2025-07

Locations